Tuberculous peritonitis in a haemodialysis patient with elevated serum CA 125 and hypercalcaemia

I. K. Wang, F. R. Chuang, K. F. Lee, C. L. Lin, H. Y. Chang, Chih Kun Huang*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

5 Scopus citations

Abstract

CA 125, a glycoprotein derived from coelomic epithelium, is used primarily as a marker of epithelial ovarian cancer. However, elevated levels of serum CA 125 have also been detected in other benign and malignant disorders. This study describes a haemodialysis patient who contracted tuberculous peritonitis associated with hypercalcaemia, erythropoietin-resistant anaemia and elevated CA 125, which normalised gradually following antituberculosis treatment. Tuberculous peritonitis should be considered in the differential diagnosis of ascites with elevated serum CA 125. Additionally, CA 125 is a useful marker for monitoring response to tuberculous peritonitis treatment.

Original languageEnglish
Pages (from-to)56-59
Number of pages4
JournalInternational Journal of Clinical Practice
Volume59
Issue numberSUPPL. 147
DOIs
StatePublished - 04 2005
Externally publishedYes

Keywords

  • CA125
  • Haemodialysis
  • Hypercalcaemia
  • Tuberculous peritonitis

Fingerprint

Dive into the research topics of 'Tuberculous peritonitis in a haemodialysis patient with elevated serum CA 125 and hypercalcaemia'. Together they form a unique fingerprint.

Cite this